哈尔滨空调股份有限公司关于公开挂牌转让控股子公司哈尔滨富山川生物科技发展有限公司股权进展暨交易结果的公告

Group 1 - The company, Harbin Air Conditioning Co., Ltd., has publicly transferred 40% equity of its subsidiary, Harbin Fushanchuan Biotechnology Development Co., Ltd., to Harbin Industrial Investment Group Co., Ltd. for a price of RMB 3.8126 million [2][4][10] - The transaction is classified as a related party transaction but does not constitute a major asset restructuring, as the buyer holds 34.03% of the company's shares [2][6] - The board of directors approved the transaction on November 21, 2025, and the contract was signed on December 29, 2025, following the confirmation of the buyer's qualifications [4][6][10] Group 2 - The subsidiary, Fushanchuan, reported a net profit of -RMB 16.0963 million for 2024, which is 218.83% of the absolute value of the company's audited net profit for the previous year [6] - The company has no outstanding debts or financial obligations to Fushanchuan, and the subsidiary has fully repaid all operational debts to the company [3][17] - The transaction is expected to optimize resource allocation and align with the company's strategic focus, as it will no longer consolidate Fushanchuan's financials [17] Group 3 - On December 29, 2025, the company received a government subsidy of RMB 1 million, which will positively impact the company's profits for the fiscal year 2025 [20] - The subsidy is classified as a government grant related to income and will be recognized in the current period's profit and loss [20]